Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses. (Q54588886)

1 June 2018

title

Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses. (English)

1 reference

1 June 2018

0 references

7

Andrew Blauvelt

1 reference

1 June 2018

author name string

Tomomitsu Miyagaki

1

1 reference

1 June 2018

Makoto Sugaya

2

1 reference

1 June 2018

Hitoshi Okochi

3

1 reference

1 June 2018

Yoshihide Asano

4

1 reference

1 June 2018

Yayoi Tada

5

1 reference

1 June 2018

Takafumi Kadono

6

1 reference

1 June 2018

Kunihiko Tamaki

8

1 reference

1 June 2018

Shinichi Sato

9

1 reference

1 June 2018

language of work or name

English

0 references

publication date

19 May 2011

1 reference

1 June 2018

Journal of Investigative Dermatology

published in

1 reference

1 June 2018

volume

131

1 reference

1 June 2018

issue

9

1 reference

1 June 2018

page(s)

1927-1935

1 reference

1 June 2018

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Genetic immunization with LYVE-1 cDNA yields function-blocking antibodies against native protein.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Alymphoplasia (aly)-type nuclear factor kappaB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Interleukin-6 stimulates α-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-κB

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Reversal of ultraviolet B-induced immunosuppression by inhibition of the extracellular signal-regulated mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Oncostatin M: foe or friend?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Molecular characterization of lymphatic endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Secondary lymphoid tissue chemokine (CCL21) is upregulated in allergic contact dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Dendritic cells: activation and maturation--applications for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Oncostatin M production by human dendritic cells in response to bacterial products

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Oncostatin M, a multifunctional cytokine

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Recent advances of MEK inhibitors and their clinical progress

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

CD19 expression in B cells is important for suppression of contact hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Structures and biological functions of IL-31 and IL-31 receptors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.135

7 January 2021

Identifiers

DOI

10.1038/JID.2011.135

1 reference

1 June 2018

1 reference

1 June 2018